We are live on ! Find out more
LVGO

Livongo Health, Inc. Common Stock
LVGO

Delisted

LVGO was delisted on the 29th of October, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Livongo Health, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 388 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 391 → 0 (-391)

100% less funds holding in top 10

Funds holding in top 10: 27 → 0 (-27)

100% less capital invested

Capital invested by funds: $7B → $0 (-$7B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 388

Holders
–
Holders Change
-391
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-27
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
388
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$734M
2
BlackRock
BlackRock
New York
-$554M
3
Morgan Stanley
Morgan Stanley
New York
-$427M
4
HI
HBK Investments
Texas
-$390M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$372M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAMU
26
Amundi Asset Management US
Massachusetts
– -$60.8M -433,954 Closed
WCMNY
27
Westchester Capital Management (New York)
New York
– -$58M -413,789 Closed
N
28
Natixis
France
– -$57.7M -411,839 Closed
TAL
29
TIG Advisors LLC
New York
– -$57.4M -409,609 Closed
Ameriprise
30
Ameriprise
Minnesota
– -$50.1M -357,440 Closed
UOC
31
UBS O'Connor
Illinois
– -$47.9M -341,950 Closed
Renaissance Technologies
32
Renaissance Technologies
New York
– -$45.7M -326,500 Closed
Mirae Asset Global Investments
33
Mirae Asset Global Investments
South Korea
– -$43.8M -316,220 Closed
AA
34
AQR Arbitrage
Connecticut
– -$43.6M -311,174 Closed
TS
35
Twin Securities
New York
– -$43M -307,166 Closed
Northern Trust
36
Northern Trust
Illinois
– -$41.4M -295,458 Closed
FTCM
37
First Trust Capital Management
Illinois
– -$39.6M -282,554 Closed
WCA
38
Whetstone Capital Advisors
Kansas
– -$39.5M -282,377 Closed
Citigroup
39
Citigroup
New York
– -$37M -263,871 Closed
Millennium Management
40
Millennium Management
New York
– -$36.6K -261,192 Closed
N
41
Nuveen
North Carolina
– -$35.8M -255,786 Closed
Deutsche Bank
42
Deutsche Bank
Germany
– -$35.1M -250,779 Closed
PAM
43
PSquared Asset Management
Switzerland
– -$35M -249,600 Closed
CCM
44
Cota Capital Management
California
– -$34.7M -247,744 Closed
WRF
45
Waddell & Reed Financial
Kansas
– -$34.5M -246,532 Closed
G
46
GenTrust
Florida
– -$34.2M -243,919 Closed
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
– -$33M -235,432 Closed
Voloridge Investment Management
48
Voloridge Investment Management
Florida
– -$32.9M -234,932 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– -$32.5M -232,252 Closed
Man Group
50
Man Group
United Kingdom
– -$32.4M -231,337 Closed
1
2
3 4 5

LVGO Hedge Fund Activity: Q4 2020 in Review

0 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Livongo Health, Inc. Common Stock (LVGO) for Q4 2020, worth a combined $0 — down 100% from $7B a quarter earlier.

Sellers outnumbered buyers: 388 funds closed out of LVGO and 0 opened new positions — a net loss of 388 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $734M sold.

  • 0 institutional investors held Livongo Health, Inc. Common Stock (LVGO) as of Q4 2020, down from 391 in Q3 2020.
  • Funds reported $0 of Livongo Health, Inc. Common Stock stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Livongo Health, Inc. Common Stock positions in Q4 2020 and 388 closed out, a net change of -388 holders.
  • The largest Livongo Health, Inc. Common Stock seller in Q4 2020 was Vanguard Group, an estimated $734M sold.

Based on aggregated 13F filings for Q4 2020.